GEN-PROBE LICENSES FROM CORIXA RIGHTS TO DEVELOP MOLECULAR DIAGNOSTIC TESTS

Gen-Probe has licensed from Corixa the rights to develop molecular diagnostic tests for approximately 50 potential genetic markers in the areas of prostate, ovarian, cervical, kidney, lung and colon cancer, the companies announced.

ArriveNet (http://press.arrivenet.com/bus/article.php/552112.html)